Please ensure Javascript is enabled for purposes of website accessibility

Why Aphria and Tilray Stocks Are Falling Today

By Keith Speights - Updated Feb 17, 2021 at 9:37AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors appear to be a little jittery about Tilray's fourth-quarter update later today.

What happened

Shares of Aphria (APHA) were falling 5.5% lower as of 10:28 a.m. EST on Wednesday after sinking as much as 12.6% earlier in the day. Tilray (TLRY) stock was down 9.6% after tumbling 11.5% earlier.

Neither Canadian cannabis producer reported any news. These declines are likely due to investors' anxiety about Tilray's fourth-quarter update scheduled for after the market close today. Aphria's and Tilray's fortunes have been intertwined since the companies announced in December that they plan to merge.  

Hand holding a white bag with an image of a green cannabis leaf on it

Image source: Getty Images.

So what

There's a good reason why investors might be jittery about Tilray's Q4 update. The company has delivered anemic quarterly results recently. In the third quarter, for example, Tilray's total revenue was flat year over year as it posted yet another net loss. 

In the big scheme of things, though, whatever Tilray reports after the market close today won't matter very much. Aphria and Tilray hope to complete their merger in the second quarter of 2021. The transaction will create the biggest cannabis company in the world based on revenue. Tilray's Q4 results will be quickly forgotten.

However, the underlying business dynamics that impact Tilray's Q4 performance could matter to the combined company. Any headwinds for the Canadian cannabis market or the U.S. hemp foods market could continue to present challenges for the "new" Tilray (62% of which will be owned by Aphria shareholders.)

Now what

These two marijuana stocks will continue to march in relative lockstep until the merger is completed. Whether that march is a pleasant one over the near term could depend heavily on what Tilray has to say later today.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Tilray Stock Quote
Aphria Stock Quote

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.